Title
Category
Credits
Event date
Cost
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$899.00
PAINWeek Digital All Acess is an online library of sessions from the PAINWeek Live Virtual Conference that you can watch anytime, anywhere. Plus, every session is certified for credit.It’s great for people who had to miss the meeting, or for those who have attended but couldn't fit every desired session into their schedule.
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
  • PAINWeek
  • AAFP
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$499.00
The enormity of CNS-related conditions poses an immense burden to public health. In 2021, there remain significant knowledge gaps among clinicians treating neurologic and psychiatric disorders. Conditions such as dementia, epilepsy, migraine, MS, and stroke require a more inclusive approach to continuing medical education.The BRAINWeek demand agenda has been crafted to address the most frequently diagnosed conditions encountered in clinical practice, with an emphasis on collaborative care among specialists and frontline practitioners. 
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$0.00
Sickle cell disease (SCD) is an inherited red blood cell disorder that affects approximately 100,000 people in the United States. SCD is characterized by extremely painful, acute pain episodes known as vaso-occlusive crises (VOC). VOC are the primary presenting morbidity of SCD and cause of hospitalization in 95% of cases. Recurrent VOC episodes have a significant, negative impact on health related quality of life and have a greater impact than cumulative organ damage.
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$0.00
Treatments targeting calcitonin gene-related peptide (CGRP) effectively treat migraine and have changed our approach to the disorder. This course will review how these medications work and provide updates on their safety and effectiveness. We will particularly focus on differences between monoclonal antibodies and small molecule antagonists against CGRP, acute and preventive treatment, and individualizing therapy for each patient.This activity is supported by an educational grant from GlaxoSmithKline
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00
  • PAINWeek
  • AANP
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
  • APA
$1,500.00